Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

3 weeks ago 8

MarketBeat

Tue, August 4, 2026 astatine 5:03 AM CDT 7 min read

Key Points

  • Hospital Stocks - Best Hospital Stocks to Buy

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) reported second-quarter 2026 integrated gross maturation of 5% and a 23% summation successful operating income astatine changeless currency, portion confirming its full-year outlook contempt weaker U.S. attraction volumes and anticipated reimbursement-related headwinds successful the 2nd half.

Chief Executive Officer Helen Giza said the company's operating-income maturation accelerated successful enactment with its planned 2026 phasing, supported by integrated gross development, borderline enlargement and savings from its FME25+ translation program. The programme generated EUR 67 cardinal of sustainable savings during the quarter, she said.

→ Lost successful Space: Why Aerospace Valuations Are Plummeting Right Now

  • Best Healthcare Stocks - Healthcare Stocks to Buy Now

The institution besides completed its archetypal EUR 1 cardinal stock repurchase programme up of docket and began a 2nd EUR 1 cardinal program. Net leverage stood astatine 2.6 times, adjacent the little extremity of Fresenius Medical Care's people scope of 2.5 to 3 times.

U.S. Treatment Growth Declines connected Referral Execution Gap

Care Delivery's U.S. same-market attraction maturation declined 0.9% successful the 2nd quarter, portion planetary same-market attraction maturation roseate 0.8%. Giza attributed the U.S. diminution to an operational shortfall successful the company's business-development process for converting diligent referrals into treatments.

→ MarketBeat Week successful Review – 07/27- 07/31

"We are not seeing a marketplace issue. We are seeing a measurement seizure contented successful presumption of getting the patients that we spot into our clinics," Giza said during the call.

Read Entire Article